Psychopharmacology & Behavioral Science

This track focuses on therapies affecting mood, cognition, and behavior. Topics include antidepressants, anxiolytics, antipsychotics, and addiction treatments. Researchers will discuss challenges in understanding mental health disorders at the molecular level. Neurobehavioral assessment tools and imaging technologies will be explored. Sessions will highlight real-world trial designs for psychiatric drugs. Attendees will gain insights into emerging therapeutic targets.

    Related Conference of Psychopharmacology & Behavioral Science

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Psychopharmacology & Behavioral Science Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in